Home
Search

Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Statement on December 2025 ACIP Meeting
WASHINGTON, D.C. – Phyllis Arthur, Executive Vice President and Head of Health Policy and Programs of the Biotechnology Innovation Organization (BIO) released the following statement on the December 2025 ACIP meeting.“For decades, the CDC’s Advisory…
Learn more
BIO Statement on the Retirement of Richard Pazdur…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on reports of the retirement of Richard Pazdur from the US FDA.“Dr. Pazdur has dedicated decades of his career…
Learn more
BIO Statement on House Passage of Mikaela Naylon…
WASHINGTON, D.C. – The Biotechnology Innovation Organization (BIO) released the following statement on today’s passage of the Mikaela Naylon Give Kids a Chance Act in the House of Representatives.“The unanimous House passage of the Mikaela Naylon…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
BIO Elects New Board Directors and Section Governing Board Chairs
June 16, 2020
The Biotechnology Innovation Organization (BIO) is pleased to announce the election of its new Executive Committee members for the 2020-2021 term. Additionally, eight new board directors and four new section governing board chairs and vice chairs…
BIO’s Dr. Clint Nesbitt Named to APLU-AAVMC Task Force on Gene Editing in Animal Agriculture
June 11, 2020
Washington, D.C. (June 11, 2020) – Dr. Clint Nesbitt, Senior Director of Science and Regulatory Affairs for Food & Agriculture at the Biotechnology Innovation Organization (BIO), was named today to a Task Force on Gene Editing in Animal…
New Report Analyzes Bioscience Industry’s Impact on Economy & Global Pandemic
June 8, 2020
The Biotechnology Innovation Organization (BIO) today released new data on the bioscience industry in the United States.The new report, The Bioscience Economy: Propelling Life-Saving Treatments, Supporting State & Local Communities,…
BIO’s Dr. McMurry-Heath Says Racism a “Chronic Disease” Plaguing Society
June 4, 2020
Will lead discussion on race and equity with industry leaders Drs. Tony Coles, Ted Love, and Jeremy Levin next week In the wake of tragic deaths and civil unrest, BIO’s President and CEO Dr. Michelle McMurry-Heath announced she will lead a panel…
Dr. Anthony Fauci, Dr.Moncef Slaoui and Top COVID-19 Thought Leaders Take Stage During BIO Digital Week
May 28, 2020
Anthony Fauci, M.D., National Institute of Allergy and Infectious Diseases Director and Moncef Slaoui, Ph.D., U.S. Operation Warp Speed Chief Advisor will speak on a special plenary session on Tuesday, June 9 during BIO Digital, a virtual conference…
Modernized Biotech Regulation Will Unleash Greater Innovation
May 14, 2020
The U.S. Department of Agriculture (USDA) released today a modernized, science-based regulatory system for plant biotechnology aimed at maintaining oversight while driving innovation. Now government and industry must do more to build an informed and…
BIO Appoints a Physician-Scientist as New President and CEO
May 14, 2020
Immunologist Michelle McMurry-Heath is Selected  for Her Global Leadership and Commitment to Innovation and Patients Former FDA Official Will Succeed Industry Leader Jim Greenwood  on June 1 as Leader of World’s Largest Biotechnology…
Dr. Moncef Slaoui “Excellent Choice” to Lead Operation Warp Speed
May 13, 2020
Following the announcement that Dr. Moncef Slaoui will lead the Trump Administration's "Operation Warp Speed" initiative, BIO’s President and CEO, Jim Greenwood, issued the following statement:  “Dr. Moncef Slaoui is an excellent choice…
New Medicine Pipeline Tracker Illustrates Unprecedented Effort to Eradicate COVID-19
May 12, 2020
The Biotechnology Innovation Organization (BIO) today unveiled a first-of-its-kind, interactive tracker of the new treatments and vaccines in the COVID-19 pipeline. This online resource illustrates the unprecedented campaign being undertaken by…
CMS Announcement an Important Step Forward for Patients, Transformative Therapies
May 11, 2020
Today, the Centers for Medicare and Medicaid Services announced that it is proposing to create a new Medicare-severity-diagnosis related group (MS-DRG) designed specifically for reimbursing providers administering CAR T-cell therapies to cancer…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today